These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9336306

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A model for the prediction of digoxin-drug interactions at the renal tubular cell level.
    Woodland C, Ito S, Koren G.
    Ther Drug Monit; 1998 Apr; 20(2):134-8. PubMed ID: 9558126
    [Abstract] [Full Text] [Related]

  • 4. From bench to bedside: utilization of an in vitro model to predict potential drug-drug interactions in the kidney: the digoxin-mifepristone example.
    Woodland C, Koren G, Ito S.
    J Clin Pharmacol; 2003 Jul; 43(7):743-50. PubMed ID: 12856388
    [Abstract] [Full Text] [Related]

  • 5. Metabolite cumulation during chronic propafenone dosing in arrhythmia.
    Kates RE, Yee YG, Winkle RA.
    Clin Pharmacol Ther; 1985 Jun; 37(6):610-4. PubMed ID: 4006362
    [Abstract] [Full Text] [Related]

  • 6. Verapamil metabolites: potential P-glycoprotein-mediated multidrug resistance reversal agents.
    Woodland C, Koren G, Wainer IW, Batist G, Ito S.
    Can J Physiol Pharmacol; 2003 Aug; 81(8):800-5. PubMed ID: 12897809
    [Abstract] [Full Text] [Related]

  • 7. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
    Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori R.
    J Pharmacol Exp Ther; 1992 Nov; 263(2):840-5. PubMed ID: 1359120
    [Abstract] [Full Text] [Related]

  • 8. Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein.
    Wakasugi H, Yano I, Ito T, Hashida T, Futami T, Nohara R, Sasayama S, Inui K.
    Clin Pharmacol Ther; 1998 Jul; 64(1):123-8. PubMed ID: 9695727
    [Abstract] [Full Text] [Related]

  • 9. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1).
    Ito S, Woodland C, Harper PA, Koren G.
    Life Sci; 1993 Jul; 53(24):PL399-403. PubMed ID: 8246676
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism of an unusual, but clinically significant, digoxin-bupropion drug interaction.
    He J, Yu Y, Prasad B, Chen X, Unadkat JD.
    Biopharm Drug Dispos; 2014 Jul; 35(5):253-63. PubMed ID: 24436229
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney.
    Okamura N, Hirai M, Tanigawara Y, Tanaka K, Yasuhara M, Ueda K, Komano T, Hori R.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1614-9. PubMed ID: 8103797
    [Abstract] [Full Text] [Related]

  • 15. Effects of coadministration of propafenone on the pharmacokinetics of digoxin in healthy volunteer subjects.
    Nolan PE, Marcus FI, Erstad BL, Hoyer GL, Furman C, Kirsten EB.
    J Clin Pharmacol; 1989 Jan; 29(1):46-52. PubMed ID: 2708548
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Toxic digoxin-drug interactions: the major role of renal P-glycoprotein.
    Koren G, Woodland C, Ito S.
    Vet Hum Toxicol; 1998 Feb; 40(1):45-6. PubMed ID: 9467211
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME, Podila L, Ely D, Almeida I.
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.